4 May 2017 - The World Health Organization (WHO) announced its plan to pilot a new project to prequalify biosimilars for cancer treatment. The decision was announced at a 2-day conference in Geneva about how to increase access to biotherapeutic medicines. The move is expected to bring down the prices of the most expensive cancer treatments available, making them more accessible to low- and middle-income countries.